Profiling the host defense responses against Candida auris in a reliable Drosophila melanogaster infection model

Abstract

The “superbug” Candida auris has been ranked as a priority fungal pathogen and is becoming a serious threat to public health. However, the underlying mechanisms of real-world pathogen–host interactions remain elusive, in part due to the lack of powerful immunocompetent animal models. Here, we report that selected wild-type strains of Drosophila melanogaster can be developed as a promising infection model to recapitulate C. auris systemic infection. The systemic and organ-specific responses to C. auris infection in vivo were evaluated, as well as the corresponding transcriptional profiling. Our findings confirmed that Toll and JAK-STAT signaling pathways mediate antifungal responses in the Drosophila model following C. auris infection. Moreover, we identified certain conserved novel factors required for host–C. auris interactions, highlighting the fly model's potential to reveal subtle immune mechanisms not readily observed in mammalian systems. Taken together, our work demonstrates that wild-type Drosophila offers a robust immunocompetent animal model for further in-depth investigation of dynamic C. auris–host interactions in vivo.

Keywords

Candida auris / Drosophila / infectious model / innate immunity

References

[1] Du H, Bing J, Hu T, Ennis CL, Nobile CJ, Huang G. Candida auris: epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020; 16:e1008921.

[2] Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017; 64: 134–140.

[3] Lionakis MS, Drummond RA, Hohl TM. Immune responses to human fungal pathogens and therapeutic prospects. Nat Rev Immunol. 2023; 23: 433–452.

[4] Chen J, Tian S, Han X, Chu Y, Wang Q, Zhou B, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020; 20: 827.

[5] Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, et al. Worsening spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 2023; 176: 489–495.

[6] Chowdhary A, Jain K, Chauhan N. Candida auris genetics and emergence. Annu Rev Microbiol. 2023; 77: 583–602.

[7] Ahmad S, Alfouzan W. Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities. Microorganisms. 2021; 9: 807.

[8] Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D, et al. Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother. 2022; 66:e0005322.

[9] Huang X, Hurabielle C, Drummond RA, Bouladoux N, Desai JV, Sim CK, et al. Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies. Cell Host Microbe. 2021; 29: 210–221.e6.

[10] Balakumar A, Das D, Datta A, Mishra A, Bryak G, Ganesh SM, et al. Single-cell transcriptomics unveils skin cell specific antifungal immune responses and IL-1Ra- IL-1R immune evasion strategies of emerging fungal pathogen Candida auris. PLoS Pathog. 2024; 20:e1012699.

[11] Datta A, Das D, Nett JE, Vyas JM, Lionakis MS, Thangamani S. Differential skin immune responses in mice intradermally infected with Candida auris and Candida albicans. Microbiol Spectr. 2023; 11:e0221523.

[12] Bryak G, Cox A, Lionakis MS, Thangamani S. Yeast and filamentous Candida auris stimulate distinct immune responses in the skin. mSphere. 2024; 9:e0005524.

[13] Wang Y, Zou Y, Chen X, Li H, Yin Z, Zhang B, et al. Innate immune responses against the fungal pathogen Candida auris. Nat Commun. 2022; 13: 3553.

[14] Xin H, Mohiuddin F, Tran J, Adams A, Eberle K. Experimental mouse models of disseminated Candida auris infection. mSphere. 2019; 4:e00339-19.

[15] Wurster S, Albert ND, Kontoyiannis DP. Candida auris bloodstream infection induces upregulation of the PD-1/PD-L1 immune checkpoint pathway in an immunocompetent mouse model. mSphere. 2022; 7:e0081721.

[16] Hager CL, Larkin EL, Long LA, Ghannoum MA. Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model. J Antimicrob Chemother. 2018; 73: 2085–2088.

[17] Herrada J, Roberts K, Gamal A, Long L, Ghannoum MA. An immunocompromised mouse model of Candida auris systemic infection. Methods Mol Biol. 2022; 2517: 317–328.

[18] Johnson CJ, Davis JM, Huttenlocher A, Kernien JF, Nett JE. Emerging fungal pathogen Candida auris evades neutrophil attack. mBio. 2018; 9:e01403-18.

[19] Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016; 1:e00189-16.

[20] Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerging Infect Dis. 2017; 23: 328–331.

[21] Hernando-Ortiz A, Mateo E, Perez-Rodriguez A, de Groot PWJ, Quindós G, Eraso E. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models. Virulence. 2021; 12: 1063–1075.

[22] Eldesouky HE, Li X, Abutaleb NS, Mohammad H, Seleem MN. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris. Int J Antimicro Ag. 2018; 52: 754–761.

[23] Hernando-Ortiz A, Eraso E, Jauregizar N, de Groot PWJ, Quindós G, Mateo E. Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model. Microbiol Spectr. 2024; 12:e0208623.

[24] Okoli I, Bignell E. Caenorhabditis elegans-Aspergillus fumigatus (nematode-mould) model for study of fungal pathogenesis. Br Microbiol Res J. 2015; 7: 93–99.

[25] Ahamefule CS, Ezeuduji BC, Ogbonna JC, Moneke AN, Ike AC, Jin C, et al. Caenorhabditis elegans as an infection model for pathogenic mold and dimorphic fungi: applications and challenges. Front Cell Infect Microbiol. 2021; 11:751947.

[26] Ferrandon D, Imler J-L, Hetru C, Hoffmann JA. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nat Rev Immunol. 2007; 7: 862–874.

[27] Wigglesworth VB. “insect”. Encyclopedia Britannica, August 26, 2025. https://www.britannica.com/animal/insect.

[28] Wolf MJ, Rockman HA. Drosophila, genetic screens, and cardiac function. Circ Res. 2011; 109: 794–806.

[29] Lemaitre B, Hoffmann J. The host defense of Drosophila melanogaster. Annu Rev Immunol. 2007; 25: 697–743.

[30] Nie L, Cai S-Y, Shao J-Z, Chen J. Toll-Like receptors, associated biological roles, and signaling networks in non-mammals. Front Immunol. 2018; 9: 1523.

[31] Tanji T, Yun E-Y, Ip YT. Heterodimers of NF-κB transcription factors DIF and Relish regulate antimicrobial peptide genes in Drosophila. Proc Natl Acad Sci USA. 2010; 107: 14715–14720.

[32] Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996; 86: 973–983.

[33] Glittenberg MT, Silas S, MacCallum DM, Gow NAR, Ligoxygakis P. Wild-type Drosophila melanogaster as an alternative model system for investigating the pathogenicity of Candida albicans. Dis Models & Mech. 2011; 4: 504–514.

[34] Quintin J, Asmar J, Matskevich AA, Lafarge M-C, Ferrandon D. The Drosophila Toll pathway controls but does not clear Candida glabrata infections. J Immunol. 2013; 190: 2818–2827.

[35] Raj S, Vinod V, Jayakumar J, Suresh P, Kumar A, Biswas R. Antifungal activity of Syzygium samarangense leaf extracts against Candida. Lett Appl Microbiol. 2021; 73: 31–38.

[36] Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, et al. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019; 74: 1904–1910.

[37] Ortiz-Roa C, Valderrama-Rios MC, Sierra-Umaña SF, Rodríguez JY, Muñetón-López GA, Solórzano-Ramos CA, et al. Mortality caused by Candida auris bloodstream infections in comparison with other candida species, a multicentre retrospective cohort. J Fungi. 2023; 9: 715.

[38] Misas E, Chow NA, Gómez OM, Muñoz JF, McEwen JG, Litvintseva AP, et al. Mitochondrial genome sequences of the emerging fungal pathogen Candida auris. Front Microbiol. 2020; 11:560332.

[39] Valanne S, Wang J-H, Rämet M. The Drosophila Toll signaling pathway. J Immunol. 2011; 186: 649–656.

[40] Brennan CA, Anderson KV. Drosophila: the genetics of innate immune recognition and response. Annu Rev Immunol. 2004; 22: 457–483.

[41] Hanson MA, Cohen LB, Marra A, Iatsenko I, Wasserman SA, Lemaitre B. The Drosophila Baramicin polypeptide gene protects against fungal infection. PLoS Pathog. 2021; 17:e1009846.

[42] Maia RM, Valente V, Cunha MA, Sousa JF, Araujo DD, Silva WA, et al. Identification of unannotated exons of low abundance transcripts in Drosophila melanogaster and cloning of a new serine protease gene upregulated upon injury. BMC Genomics. 2007; 8: 249.

[43] Chamy LE, Leclerc V, Caldelari I, Reichhart J-M. Sensing of ‘danger signals’ and pathogen-associated molecular patterns defines binary signaling pathways ‘upstream’ of Toll. Nat Immunol. 2008; 9: 1165–1170.

[44] Bruno M, Kersten S, Bain JM, Jaeger M, Rosati D, Kruppa MD, et al. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris. Nat Microbiol. 2020; 5: 1516–1531.

[45] Levy F, Rabel D, Charlet M, Bulet P, Hoffmann JA, Ehret-Sabatier L. Peptidomic and proteomic analyses of the systemic immune response of Drosophila. Biochimie. 2004; 86: 607–616.

[46] Mortimer NT, Kacsoh BZ, Keebaugh ES, Schlenke TA. Mgat1-dependent N-glycosylation of membrane components primes Drosophila melanogaster blood cells for the cellular encapsulation response. PLoS Pathog. 2012; 8:e1002819.

[47] Lemaitre B, Hoffmann J. The host defense of Drosophila melanogaster. Annu Rev Immunol. 2007; 25: 697–743.

[48] Weber ANR, Tauszig-Delamasure S, Hoffmann JA, Lelièvre E, Gascan H, Ray KP, et al. Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling. Nat Immunol. 2003; 4: 794–800.

[49] Tauszig-Delamasure S, Bilak H, Capovilla M, Hoffmann JA, Imler J-L. Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections. Nat Immunol. 2002; 3: 91–97.

[50] Ding G, Xiang X, Hu Y, Xiao G, Chen Y, Binari R, et al. Coordination of tumor growth and host wasting by tumor-derived Upd3. Cell Rep. 2021; 36:109553.

[51] Stokes BA, Yadav S, Shokal U, Smith LC, Eleftherianos I. Bacterial and fungal pattern recognition receptors in homologous innate signaling pathways of insects and mammals. Front Microbiol. 2015; 6: 19.

[52] Callus BA, Mathey-Prevot B. SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc. Oncogene. 2002; 21: 4812–4821.

[53] Amoyel M, Bach EA. Functions of the Drosophila JAK-STAT pathway: lessons from stem cells. JAK-STAT. 2012; 1: 176–183.

[54] Roman G, Endo K, Zong L, Davis RL. P{Switch}, a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci USA. 2001; 98: 12602–12607.

[55] Fox RM, Hanlon CD, Andrew DJ. The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity. J Cell Biol. 2010; 191: 479–492.

[56] Stephenson R, Hosler MR, Gavande NS, Ghosh AK, Weake VM. Characterization of a Drosophila ortholog of the Cdc7 kinase. J Biol Chem. 2015; 290: 1332–1347.

[57] Briano F, Magnasco L, Sepulcri C, Dettori S, Dentone C, Mikulska M, et al. Candida auris candidemia in critically ill, colonized patients: cumulative incidence and risk factors. Infect Dis Ther. 2022; 11: 1149–1160.

[58] Torres SR, Pichowicz A, Torres-Velez F, Song R, Singh N, Lasek-Nesselquist E, et al. Impact of Candida auris infection in a neutropenic murine model. Antimicrob Agents Chemother. 2020; 64:e01625-19.

[59] Wurster S, Albert ND, Kontoyiannis DP. Drosophila melanogaster as a rapid and reliable in vivo infection model to study the emerging yeast pathogen Candida auris. Methods Mol Biol. 2022; 2517: 299–316.

[60] Kurakado S, Matsumoto Y, Sugita T. Comparing the virulence of four major clades of Candida auris strains using a silkworm infection model: Clade IV isolates had higher virulence than the other clades. Med Mycol. 2023; 61:myad108.

[61] Wang X, Bing J, Zheng Q, Zhang F, Liu J, Yue H, et al. The first isolate of Candida auris in China: clinical and biological aspects. Emerg Microbes Infect. 2018; 7: 1–9.

[62] Li J, Hsu H-C, Ding Y, Li H, Wu Q, Yang P, et al. Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis. Arthritis Rheum. 2014; 66: 2368–2379.

[63] Burton DR, Dwek RA. Sugar determines antibody activity. Science. 2006; 313: 627–628.

[64] Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature. 2014; 514: 638–641.

[65] Hurd EA, Domino SE. Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect Immun. 2004; 72: 4279–4281.

[66] Cerenius L, Lee BL, Söderhäll K. The proPO-system: pros and cons for its role in invertebrate immunity. Trends Immunol. 2008; 29: 263–271.

[67] Liu H, Jiravanichpaisal P, Cerenius L, Lee BL, Söderhäll I, Söderhäll K. Phenoloxidase is an important component of the defense against Aeromonas hydrophila infection in a crustacean, Pacifastacus leniusculus. J Biol Chem. 2007; 282: 33593–33598.

[68] Nappi A, Poirié M, Carton Y. The role of melanization and cytotoxic by-products in the cellular immune responses of Drosophila against parasitic wasps. Adv Parasitol. 2009; 70: 99–121.

[69] Eleftherianos I, Revenis C. Role and importance of phenoloxidase in insect hemostasis. J Innate Immun. 2011; 3: 28–33.

[70] Binggeli O, Neyen C, Poidevin M, Lemaitre B. Prophenoloxidase activation is required for survival to microbial infections in Drosophila. PLoS Pathog. 2014; 10:e1004067.

[71] Zuberova M, Fenckova M, Simek P, Janeckova L, Dolezal T. Increased extracellular adenosine in Drosophila that are deficient in adenosine deaminase activates a release of energy stores leading to wasting and death. Dis Models Mech. 2010; 3: 773–784.

[72] Quintana FJ, Cohen IR. Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol. 2005; 175: 2777–2782.

[73] Tao L, Zou H, Huang Z. Effects of Helicobacter pylori and heat shock protein 70 on the proliferation of human gastric epithelial cells. Gastroenterol Res Pract. 2014; 2014: 1–5.

[74] Saraswati SSK, Rana AK, Singh A, Anang V, Singh A, Natarajan K. HSP-27 and HSP-70 negatively regulate protective defence responses from macrophages during mycobacterial infection. Microb Infect. 2023; 25:105126.

[75] Evans CJ, Liu T, Girard JR, Banerjee U. Injury-induced inflammatory signaling and hematopoiesis in Drosophila. Proc Natl Acad Sci USA. 2022; 119:e2119109119.

[76] Buchon N, Broderick NA, Poidevin M, Pradervand S, Lemaitre B. Drosophila intestinal response to bacterial infection: activation of host defense and stem cell proliferation. Cell Host Microbe. 2009; 5: 200–211.

[77] Dostert C, Jouanguy E, Irving P, Troxler L, Galiana-Arnoux D, Hetru C, et al. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of Drosophila. Nat Immunol. 2005; 6: 946–953.

[78] Arbouzova NI, Zeidler MP. JAK/STAT signalling in Drosophila: insights into conserved regulatory and cellular functions. Development. 2006; 133: 2605–2616.

[79] Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 1995; 14: 2857–2865.

[80] Tiefenböck SK, Baltzer C, Egli NA, Frei C. The Drosophila PGC-1 homologue Spargel coordinates mitochondrial activity to insulin signalling. EMBO J. 2010; 29: 171–183.

[81] Mukherjee S, Basar MA, Davis C, Duttaroy A. Emerging functional similarities and divergences between Drosophila Spargel/dPGC-1 and mammalian PGC-1 protein. Front Genet. 2014; 5: 216.

[82] Sampieri L, Di Giusto P, Alvarez C. CREB3 transcription factors: ER-Golgi stress transducers as hubs for cellular homeostasis. Front Cell Dev Biol. 2019; 7: 123.

[83] Cui W, Liu D, Gu W, Chu B. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis. Cell Death Differ. 2021; 28: 2536–2551.

[84] Ma X, Wang Q, Ren K, Xu T, Zhang Z, Xu M, et al. A review of antimicrobial peptides: structure, mechanism of action, and molecular optimization strategies. Fermentation. 2024; 10: 540.

[85] Imler JL, Hoffmann JA. Toll receptors In innate immunity. Trends Cell Biol. 2001; 11: 304–311.

[86] Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013; 29: 15–21.

[87] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15: 550.

[88] Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. 2012; 16: 284–287.

[89] Hu Y, Flockhart I, Vinayagam A, Bergwitz C, Berger B, Perrimon N, et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinform. 2011; 12: 357.

RIGHTS & PERMISSIONS

2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.